Resistance to CD19 Immunotherapy in B-Cell ALL Is Associated with Loss of CD19 and CD22 and an Enhanced Vulnerability to B Cell Receptor Signaling Inhibition
Publication/Presentation Date
11-2022
Volume
140
Issue
1
First Page
3480
Last Page
3482
Published In/Presented At
Disciplines
Medicine and Health Sciences
Department(s)
Department of Pathology and Laboratory Medicine
Document Type
Article
COinS